Valneva @valnevaSE Twitter profile

Last Seen Profiles

@helligdrom

@Jayden_Tha

@harunhnz

@aidounaiwu

@Di2765

@jd_kaimei

@stopkookminpls

@polar_lv

@Rp_QSMP

@DeakinsMilo

@bob_plunket

@le_flos

@CoryLankshear

@JesusMa2594463

@EnatsukoNa42561

@SamanthaCZ988

@5C28BfyQpxRI7Ja

@wuIan

@i_iabi

@mmnyatorihiki

@nathanj3001

@Khusihotty

@Sukainh_Alherz

@gimmingyu383761

@itsmark0904

@antburke23

@PaulieAronson

@CHVRCHESPEDIA

@reyzinhoofc

@VixenVoyages

@SacAnime

@AldossaryYousef

@stw_pdg

@mo__to_

@BajuraEstefania

@bokeplokalmalam

Valneva

@valnevaSE

3 years

Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

64

243

493

Valneva

@valnevaSE

3 years

Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant

0

151

418

Valneva

@valnevaSE

3 years

Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001

38

140

346

Valneva

@valnevaSE

3 years

Take a look at the positive results from the pivotal Phase 3 trial of Valneva’s inactivated, adjuvanted #COVID19 #vaccine candidate VLA2001

26

178

345

Valneva

@valnevaSE

3 years

Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

30

132

309

Valneva

@valnevaSE

3 years

Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001

30

98

272

Valneva

@valnevaSE

3 years

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

30

98

256

Valneva

@valnevaSE

3 years

Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site

11

86

223

Valneva

@valnevaSE

3 years

Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

20

81

210

Valneva

@valnevaSE

3 years

Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001

25

70

207

Valneva

@valnevaSE

2 years

Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine

20

59

206

Valneva

@valnevaSE

3 years

Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001 🇧🇭

16

63

205

Valneva

@valnevaSE

3 years

Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001

0

57

189

Valneva

@valnevaSE

2 years

Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine

21

95

185

Valneva

@valnevaSE

2 years

We were delighted to welcome @ScotGovFM @NicolaSturgeon to our Livingston vaccine manufacturing site today, where she met staff who are playing a critical role in the manufacture of our inactivated #COVID19 vaccine candidate

0

66

189

Valneva

@valnevaSE

2 years

Valneva Receives Positive CHMP Opinion for Marketing Authorization of its Inactivated COVID-19 Vaccine Candidate in Europe

43

66

183

Valneva

@valnevaSE

3 years

Do you want to know how our inactivated #COVID19 vaccine candidate works? Check out this video to learn more:

14

58

178

Valneva

@valnevaSE

3 years

Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001

20

76

180

Valneva

@valnevaSE

2 years

Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement

89

146

171

Valneva

@valnevaSE

3 years

Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate

0

39

169

Valneva

@valnevaSE

3 years

Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine Program VLA2001

Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine...

Saint-Herblain (France), December 2, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirmed that the European Medicines Agency (EMA) has started a rolling...

valneva.com

EU Medicines Agency

@EMA_News

3 years

‼️ EMA starts #RollingReview of Valneva’s #COVID19vaccine . Studies in adults show that this inactivated vaccine triggers the production of antibodies that target the #coronavirus . 👉

28

82

212

14

57

153

Valneva

@valnevaSE

3 years

Valneva Awarded up to £20 Million by Scottish Enterprise to Advance Vaccine Development

0

47

150

Valneva

@valnevaSE

2 years

Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001

31

45

148

Valneva

@valnevaSE

3 years

Independent vaccine expert Otfried Kistner discussed Valneva's #inactivated #COVID19 #vaccine candidate on @PULS24news , calling it a potential "great alternative" for those who want a vaccine based on a proven technology. Click here to watch (in German):

14

59

142

Valneva

@valnevaSE

3 years

Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

10

64

153

Valneva

@valnevaSE

3 years

Valneva Comments on COV-Boost Clinical Trial Data

19

51

139

Valneva

@valnevaSE

3 years

“Fill and finish” is the final step of #vaccine #manufacturing , when doses are bottled and made ready for delivery. At Valneva, this takes place at our Solna, Sweden location. Watch the video below for an inside look:

29

47

140

Valneva

@valnevaSE

2 years

First doses of Valneva's inactivated #COVID19 #vaccine were shipped from our site in Sweden & have arrived in Bahrain. Bahrain’s Health Minister, CEO of the NHRA & other officials joined the French Ambassador & Valneva executives for this important event

0

39

138

Valneva

@valnevaSE

2 years

EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate

12

43

134

Valneva

@valnevaSE

3 years

As 2021 comes to a close, we’d like to thank the entire Valneva team for their continued effort, hard work and dedication throughout the past twelve months. We look forward to what’s in store for us in 2022 and beyond!

9

23

131

Valneva

@valnevaSE

3 years

Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate

10

42

131

Valneva

@valnevaSE

3 years

Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

0

37

127

Valneva

@valnevaSE

3 years

#DYK that in 2021 #COVID19 vaccine outputs were estimated at over 12 billion doses & are expected to hit 24 billion by mid-2022, according to the @IFPMA ? () Take an inside look at our GMP manufacturing facilities in Scotland:

36

41

122

Valneva

@valnevaSE

3 years

Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

0

39

122

Valneva

@valnevaSE

3 years

Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

0

28

119

Valneva

@valnevaSE

2 years

We are grateful to everyone who has contributed to the clinical trials of our inactivated #COVID19 vaccine - from partners to investigators and participants. Yesterday's Conditional Marketing Authorization from @MHRAgovuk highlights the value of collaboration. #VaccinesWork

National Institute for Health and Care Research

@NIHRresearch

2 years

Regulators at @MHRAgovuk have today approved the use of the Valneva vaccine in the UK. We would like to recognise and thank all the research staff and the 4,000 participants across the UK involved in the study, for their efforts, patience and altruism.

2

15

39

14

24

120

Valneva

@valnevaSE

3 years

Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate

0

30

115

Valneva

@valnevaSE

3 years

Click here to watch a video on Valneva’s inactivated, adjuvanted #COVID19 #vaccine candidate, VLA2001:

12

50

108

Valneva

@valnevaSE

3 years

Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine

12

47

110

Valneva

@valnevaSE

2 years

Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikungunya Vaccine Candidate

5

30

106

Valneva

@valnevaSE

3 years

Valneva Reports Full Year 2021 Revenue and Cash; Provides First 2022 Guidance

0

25

99

Valneva

@valnevaSE

3 years

Valneva to Present its Chikungunya Vaccine Candidate at the ASTMH 2021 Annual Meeting

7

27

98

Valneva

@valnevaSE

2 years

Valneva Confirms WHO Recommendations for its Inactivated COVID-19 Vaccine

9

26

95

Valneva

@valnevaSE

3 years

Today we’ve met a big milestone, with the first volunteer being vaccinated in the Phase 3 trial of our inactivated #COVID19 vaccine candidate - especially exciting to be taking place during #WorldImmunizationWeek ! To find out more about taking part visit:

10

34

94

Valneva

@valnevaSE

2 years

#ICYMI We successfully completed the pivotal Phase 3 trial of our single-shot chikungunya vaccine candidate, VLA1553, early last month. Check out this @biospace article for more:

9

29

95

Valneva

@valnevaSE

3 years

Valneva wishes you a magical holiday season! #BaanDekFoundation #SeasonsGreetings

11

20

87

Valneva

@valnevaSE

2 years

Valneva Reports Further Positive Phase 3 Immunogenicity and the First Heterologous Booster Results for its Inactivated, Adjuvanted COVID-19 Vaccine VLA2001

11

28

86

Valneva

@valnevaSE

10 months

Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ®

9

39

90

Valneva

@valnevaSE

3 years

Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine Candidate

7

22

88

Valneva

@valnevaSE

3 years

✨We’re honored to be on @Labiotech_eu 's list of 20 European biotechs to watch in 2022. Here’s to a year full of new milestones!🌟 #biotech #vaccines #COVID19 #chikungunya

The 20 European Biotech Companies to Watch in 2022

Here’s a list of 20 European biotech companies likely to make a big splash in the biotechnology sector over the next year.

www.labiotech.eu

7

19

88

Valneva

@valnevaSE

3 years

#TropMed21 - Today, Valneva’s Chief Medical Officer, Juan Carlos Jaramillo, MD presented “Chikungunya: Phase 3 Clinical Development of a Single-shot Live-attenuated Vaccine” at the @ASTMH 2021 Annual Meeting

5

25

88

Valneva

@valnevaSE

2 years

European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine

33

34

86

Valneva

@valnevaSE

2 years

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

4

32

81

Valneva

@valnevaSE

3 years

Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

13

42

80

Valneva

@valnevaSE

2 years

Valneva Initiates Heterologous Booster Trial of Inactivated COVID-19 Vaccine Candidate

6

22

80

Valneva

@valnevaSE

4 years

Valneva Announces UK Government Exercise of Option for 40 Million Doses of its Inactivated, Adjuvanted COVID-19 Vaccine

6

45

80

Valneva

@valnevaSE

3 years

The first batches of our #COVID19Vaccine have arrived at our site in #Sweden , where we are delighted to announce the first vials have been filled. Working across Europe, we are proud to be contributing to global efforts against #COVID19 . #EuropeanInnovation #vaccines

5

28

75

Valneva

@valnevaSE

2 years

🇩🇪 The Standing Vaccination Commission (STIKO) has issued recommendations for the use of Valneva’s COVID-19 vaccine in Germany

Bundesgesundheitsministerium

@BMG_Bund

2 years

Das Stellungnahmeverfahren zur neuen Impfempfehlung der Ständigen Impfkommission ( #STIKO ) wurde eingeleitet: Personen ab 18 Jahren wird künftig alternativ zu den bereits empfohlenen COVID-19-Impfstoffen der #Totimpfstoff #Valneva zur Grundimmunisierung empfohlen.

59

7

25

16

15

74

Valneva

@valnevaSE

2 years

Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate, Host Symposium at NECTM8

4

16

73

Valneva

@valnevaSE

3 years

Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate

9

29

71

Valneva

@valnevaSE

2 years

We are thrilled to inaugurate our new facility in #Sweden today with Social Affairs Minister @lenahallengren . The state-of-the-art Hans Wigzell Vaccine Facility will allow us to fill & distribute millions of doses per year and is an expansion of our longstanding presence in Solna

1

19

72

Valneva

@valnevaSE

2 years

Valneva is an established vaccine company. Our primary focus is the development & commercialization of prophylactic vaccines for #InfectiousDiseases with significant unmet medical need. Learn more about us here: #AdvancingVaccinesForBetterLives

4

11

71

Valneva

@valnevaSE

1 year

Valneva Announces Publication of its Chikungunya Vaccine Candidate Phase 3 Data in The Lancet

1

20

69

Valneva

@valnevaSE

2 years

Dr. Christoph Jandl (second from the left), Head of Medical Affairs, Valneva Austria, presenting our inactivated whole-virus #COVID19 vaccine technology at today’s @OEVIH_AT Press Briefing. The briefing was focused on broadening the COVID-19 vaccine and prophylactic portfolio.

Österreichischer Verband der Impfstoffhersteller

@OEVIH_AT

2 years

Beim heutigen ÖVIH-Pressegespräch () zur COVID-19-Impfungen sprachen Expert*innen zu den Themen Technologien, Varianten & Prophylaxe.

2

3

12

0

14

70

Valneva

@valnevaSE

2 years

Valneva Announces Publication of its COVID-19 Vaccine Phase 3 Data in The Lancet Infectious Diseases

10

22

69

Valneva

@valnevaSE

2 years

Valneva Sweden Managing Director Janet Hoogstraate recently spoke about the first commercial shipment of Valneva’s inactivated #COVID19 vaccine to leave the Solna facility for Bahrain. “This is a major milestone for us at Valneva…” she said.

Valneva har gjort första svenska leveransen av covidvaccin – "En stor milstolpe"

Valneva Sweden har nu skickat de första doserna av sitt covid-19-vaccin till Bahrain, där vaccinkandidaten har fått ett nödgodkännande.

www.lifesciencesweden.se

0

17

66

Valneva

@valnevaSE

3 years

At Valneva, we develop, produce and commercialize prophylactic vaccines for infectious diseases with significant unmet medical need. Learn more about several of our vaccines in development here:

3

19

64

Valneva

@valnevaSE

3 years

We're creating a new high-level vaccine manufacturing facility in Livingston, Scotland, to boost production capacity for our inactivated #COVID19 vaccine. Today, our CEO Thomas Lingelbach was pleased to join the project leadership team for its first on site meeting. @BouyguesESUK

10

23

69

Valneva

@valnevaSE

3 years

#DYK that there are no preventative vaccines or treatments available for the chikungunya virus, a viral disease transmitted to humans by infected mosquitoes? At Valneva, we’re dedicated to developing a vaccine for this major unmet need. Learn more here:

3

11

64

Valneva

@valnevaSE

2 years

Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences

4

16

61

Valneva

@valnevaSE

2 years

. @ScotGovFM @NicolaSturgeon and Business Minister @Ivan_McKee visited Valneva's new state-of-the-art large-scale manufacturing plant, which is being operationalized with support from @scotent to boost existing vaccine production capacity & create critical national infrastructure

0

22

64

Valneva

@valnevaSE

2 years

Valneva and Pfizer Announce Closing of Equity Investment

4

19

63

Valneva

@valnevaSE

2 years

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

1

18

64

Valneva

@valnevaSE

2 years

Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

1

18

65

Valneva

@valnevaSE

2 years

Valneva Provides Regulatory Update on its Inactivated COVID-19 Vaccine Candidate

14

22

62

Valneva

@valnevaSE

2 years

Today, the Valneva team were honored to ring the opening bell for @Nasdaq . We would like to thank all our employees, our partners and our shareholders for their continued dedication and support and we look forward to a great year in 2023!

3

9

60

Valneva

@valnevaSE

2 years

Valneva Joins Euronext’s Tech Leaders Index #EuronextTechLeaders @Euronext

4

9

63

Valneva

@valnevaSE

2 years

Valneva’s success stems from the dedication and expertise of over 750 employees spanning the whole value chain, from R&D to commercialization. Learn more in our 2021 Annual Business Report:

1

8

60

Valneva

@valnevaSE

3 years

Valneva Files Registration Statement for Proposed United States Initial Public Offering

1

24

60

Valneva

@valnevaSE

2 years

Valneva Announces Successful Outcome of its AGM and Appointment of two New Supervisory Board Members

0

9

61

Valneva

@valnevaSE

3 years

Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate

2

17

60

Valneva

@valnevaSE

2 years

Valneva Initiates Rolling Submission of FDA Biologics License Application for its Single-Shot Chikungunya Vaccine Candidate

1

18

60

Valneva

@valnevaSE

3 years

Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate

2

34

61

Valneva

@valnevaSE

2 years

Today is #ClinicalTrialAwarenessDay and we want to thank the healthcare professionals, medical researchers and volunteers who strive to make a difference and contribute to the development of new solutions for patients around the world. #Research #ClinicalTrials #ThankYou

7

14

60

Valneva

@valnevaSE

2 years

Valneva Confirms Amendment of Advance Purchase Agreement with European Commission for Valneva’s Inactivated COVID-19 Vaccine

6

21

57

Valneva

@valnevaSE

2 years

Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate

1

15

59

Valneva

@valnevaSE

4 years

Valneva in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate

0

22

60

Valneva

@valnevaSE

2 years

Following the delivery of the first doses of our #inactivated whole-virus #COVID19 vaccine candidate to Bahrain, Valneva CMO @JCJaramillo_CMO appeared live on Bahrain International TV's "Inside Edition" program:

Panoramic Edition | 5-4-2022

Valneva’s Chief Medical Officer Dr. Juan Carlos Jaramillo expresses pleasure in Bahrain's use authorization to the COVID-19 vaccine developed by France’s Val...

www.youtube.com

0

19

60

Valneva

@valnevaSE

4 years

We are very proud that @EmmanuelMacron cited Valneva while speaking about the fight against #COVID19 following yesterday’s European Council meeting

LCI

@LCI

4 years

▶ Conseil européen : #EmmanuelMacron s'exprime. 🗣 #Vaccination : "L'UE se met en capacité de produire de manière beaucoup plus autonome et durable car il est vraisemblable que nous aurons à vivre avec ce virus dans la durée". 📺 #Le20HdeLCI avec @EliMartichoux .

18

23

0

17

61

Valneva

@valnevaSE

2 years

#WorldImmunizationWeek starts today. From the beginning, Valneva’s vision has always been to contribute to a world where no one dies or suffers from a vaccine-preventable disease. We’re proud to support this campaign again in 2022 #LongLifeForAll @WHO

3

13

60

Valneva

@valnevaSE

2 years

On Wednesday, Valneva was pleased to host Chris Barton CMG, Her Majesty’s Trade Commissioner for Europe; Emma Baines, Deputy Head of Mission; Bronwen Moore, Country Director DIT Austria; and Markus Hauser, DIT/Head of Inward Investment at our site in Vienna, Austria

0

13

57

Valneva

@valnevaSE

2 years

#ICYMI @Gulf_News , the leading English-language paper in the United Arab Emirates, covered Bahrain’s recent approval of our #COVID19 vaccine. Read more here: #vaccines

Bahrain approves emergency use of French vaccine VLA2001

Orders 1m doses of France’s Valneva vaccine shipment to arrive end of March

gulfnews.com

0

16

57

Valneva

@valnevaSE

2 years

Valneva Reports Full Year 2021 Results and Provides Corporate Updates

0

12

57

Valneva

@valnevaSE

2 years

"Usually, vaccines’ effectiveness is measured by an antibody response, but scientists are pushing for T cells to be recognized as a factor in long-term vaccine success." #COVID19 #vaccines #TCells #immuneresponse @biospace

60 Scientists Sign Letter Petitioning FDA for T Cell Recognition

As Omicron dominates the COVID-19 landscape, scientists are urging the FDA to reconsider how the agency defines immune responses.

www.biospace.com

9

17

58

Valneva

@valnevaSE

2 years

Valneva Reports Q1 2022 Results and Provides Corporate Updates

3

12

55

Valneva

@valnevaSE

2 years

Valneva

@valnevaSE

2 years

Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

1

18

65

4

12

55

Valneva

@valnevaSE

3 years

Today, we announced the pricing of our #IPO and began trading on @Nasdaq under the ticker symbol $VALN. We are so excited for this next chapter as a company and cannot thank our team enough for their commitment to the Valneva mission! #ValnevaNasdaqIPO 🎉🔔

6

13

56

Valneva

@valnevaSE

3 years

The #Chikungunya virus is transmitted to people by mosquito bites. It can be imported to new areas by infected travelers. There are no preventive vaccines so people traveling to endemic countries should take precautionary measures. Learn more from @CDCgov :